Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1
-
- Li-Jun Ma
- Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Su-Li Mao
- Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Kevin L. Taylor
- Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Talerngsak Kanjanabuch
- Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
-
- YouFei Guan
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
-
- YaHua Zhang
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Nancy J. Brown
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Larry L. Swift
- Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Owen P. McGuinness
- Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
-
- David H. Wasserman
- Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Douglas E. Vaughan
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
-
- Agnes B. Fogo
- Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee
書誌事項
- 公開日
- 2004-02-01
- DOI
-
- 10.2337/diabetes.53.2.336
- 公開者
- American Diabetes Association
この論文をさがす
説明
<jats:p>Increased plasminogen activator inhibitor 1 (PAI-1) has been linked to not only thrombosis and fibrosis but also to obesity and insulin resistance. Increased PAI-1 levels have been presumed to be consequent to obesity. We investigated the interrelationships of PAI-1, obesity, and insulin resistance in a high-fat/high-carbohydrate (HF) diet–induced obesity model in wild-type (WT) and PAI-1–deficient mice (PAI-1−/−). Obesity and insulin resistance developing in WT mice on an HF diet were completely prevented in mice lacking PAI-1. PAI-1−/− mice on an HF diet had increased resting metabolic rates and total energy expenditure compared with WT mice, along with a marked increase in uncoupling protein 3 mRNA expression in skeletal muscle, likely mechanisms contributing to the prevention of obesity. In addition, insulin sensitivity was enhanced significantly in PAI-1−/− mice on an HF diet, as shown by euglycemic-hyperinsulinemic clamp studies. Peroxisome proliferator–activated receptor (PPAR)-γ and adiponectin mRNA, key control molecules in lipid metabolism and insulin sensitivity, were maintained in response to an HF diet in white adipose tissue in PAI-1−/− mice, contrasting with downregulation in WT mice. This maintenance of PPAR-γ and adiponectin may also contribute to the observed maintenance of body weight and insulin sensitivity in PAI-1−/− mice. Treatment in WT mice on an HF diet with the angiotensin type 1 receptor antagonist to downregulate PAI-1 indeed inhibited PAI-1 increases and ameliorated diet-induced obesity, hyperglycemia, and hyperinsulinemia. PAI-1 deficiency also enhanced basal and insulin-stimulated glucose uptake in adipose cells in vitro. Our data suggest that PAI-1 may not merely increase in response to obesity and insulin resistance, but may have a direct causal role in obesity and insulin resistance. Inhibition of PAI-1 might provide a novel anti-obesity and anti–insulin resistance treatment.</jats:p>
収録刊行物
-
- Diabetes
-
Diabetes 53 (2), 336-346, 2004-02-01
American Diabetes Association
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1363670319940325632
-
- NII論文ID
- 30026270738
-
- ISSN
- 1939327X
- 00121797
-
- データソース種別
-
- Crossref
- CiNii Articles
